|
|||||
|
|
Phase 1b study of pasireotide,everolimus, and selective internal radioembolization therapy for unresectable neuroendocrine tumors with hepatic metastases |
|
| Authors: | Hyun S. Kim MD Walid L. Shaib MD Chao Zhang PhD Ganji Purnachandra Nagaraju PhD Christina Wu MD Olatunji B. Alese MD Zhengjia Chen PhD Edith Brutcher NP Meredith Renfroe CCRP Bassel F. El‐Rayes MD |
| Affiliation: | 1. Division of Interventional Radiology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut;2. Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia;3. Department of Biostatistics, Emory University, Atlanta, Georgia;4. Clinical Trials Office, Winship Cancer Institute, Emory University, Atlanta, Georgia |
| Abstract: | |
| Keywords: | everolimus liver metastasis pasireotide phase 1b selective internal radioembolization (SIRT) unresectable neuroendocrine tumor |